Asia-Pacific Immunosuppressant Drugs Market 2019-2028

MARKET OUTLOOK

Research by the publishershows that the Asia-Pacific immunosuppressant drugs market will be fast progressing at a CAGR of 5.32% in terms of revenue over the forecast period of 2019-2028. China, India, Japan, South Korea, Australia & New Zealand, ASEAN countries, and Rest of APAC together form the market in this region.
South Korea is emerging as a medical hub in the Northeast Asian region, and is as well a key contributor to global healthcare innovation. The global pharmaceutical industries have taken note of the rapid progression of the country’s pharmaceutical & biotech industries over the past few years, and deem it to be a nation possessing new drug R&D capabilities. There is a significant demand for immunosuppressant drugs in South Korea, and the growth of the pharma industry has helped increase the production of these drugs. This has helped the Korean immunosuppressant drugs market to prosper over the forecasted period.

Furthermore, all types of organ transplantation processes, such as those of heart, kidney, liver, etc., are performed in the country. 3,908 organ transplantations were performed in South Korea in 2018. This shows that there is a growth in demand for these surgical procedures in the country. It is necessary to provide immunosuppressants to patients after a transplant, as these drugs are necessary for the life and long-term success of the transplantation procedure. Thus, a growth in the number of organ transplants implies a growth in the demand for immunosuppressants. This increasing demand is propelling the growth of South Korea’s immunosuppressant drugs market.

COMPETITIVE OUTLOOK

Some of the companies present in this market are Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc), Intas Pharmaceuticals Ltd (Accord Healthcare), Astellas Pharma Inc, Sanofi, Cipla Ltd, Dr Reddys Laboratories Ltd, Bristol-Myers Squibb Company, and Novartis AG.

1. Asia-Pacific Immunosuppressant Drugs Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Organ Transplantation Leads the Market by End-User
2.2.2. Pharmaceutical Industry Showing Growth Trends
2.2.3. Impact of Covid-19 on Transplant Recipients
2.3. Evolution & Transition of Immunosuppressant Drugs
2.4. Porter's Five Force Analysis
2.4.1. Threat of New Entrants
2.4.2. Threat of Substitute
2.4.3. Bargaining Power of Suppliers
2.4.4. Bargaining Power of Buyers
2.4.5. Threat of Competitive Rivalry
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Market Drivers
2.7.1. Demand from Organ Transplantation
2.7.2. Rise in the Number of Autoimmune Disorders
2.8. Market Restraints
2.8.1. Side-Effects of Immunosuppressant Drugs
2.9. Market Opportunities
2.9.1. Demand from Emerging Economies
2.9.2. Exports of Drugs and Medicine Worldwide on Rise
2.10. Market Challenges
2.10.1. Lack of Awareness About Organ Donation

3. Asia-Pacific Immunosuppressant Drugs Market Outlook – by Drug Class

3.1. Corticosteroids
3.2. Monoclonal Antibodies
3.3. Calcineurin Inhibitors
3.4. Mtor Inhibitors
3.5. Others

4. Asia-Pacific Immunosuppressant Drugs Market Outlook - by Distribution Channel

4.1. Hospital Pharmacies
4.2. Retail Pharmacies
4.3. Online Pharmacies

5. Asia-Pacific Immunosuppressant Drugs Market Outlook - by End-User

5.1. Organ Transplantation
5.2. Autoimmune Disorders
5.3. Others

6. Asia-Pacific Immunosuppressant Drugs Market – Regional Outlook

6.1. China
6.2. Japan
6.3. India
6.4. South Korea
6.5. Asean Countries
6.6. Australia & New Zealand
6.7. Rest of Asia-Pacific

7. Competitive Landscape

7.1. Abbvie Inc
7.2. Allergan (Acquired by Abbvie Inc)
7.3. Astellas Pharma Inc
7.4. Bristol-Myers Squibb Company
7.5. Cipla Ltd
7.6. Dr Reddys Laboratories Ltd
7.7. F Hoffmann-La Roche Ltd
7.8. GlaxoSmithKline plc
7.9. Intas Pharmaceuticals Ltd (Accord Healthcare)
7.10. Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc)
7.11. Mylan Nv
7.12. Novartis AG
7.13. Pfizer Inc
7.14. Sanofi
7.15. Veloxis Pharmaceuticals Inc

8. Methodology & Scope

8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables

Table 1: Asia-Pacific Immunosuppressant Drugs Market, by Country, 2019-2028 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Side-Effects of Immunosuppressant Drugs
Table 5: Top 15 Positive Net Exports Countries and Negative Net Exports for Drugs & Medicines Countries
Table 6: Asia-Pacific Immunosuppressant Drugs Market, by Drug Class, 2019-2028 (In $ Million)
Table 7: Asia-Pacific Immunosuppressant Drugs Market, by Distribution Channel, 2019-2028 (In $ Million)
Table 8: Asia-Pacific Immunosuppressant Drugs Market, by End-User, 2019-2028 (In $ Million)
Table 9: Asia-Pacific Immunosuppressant Drugs Market, by Country, 2019-2028 (In $ Million)

List of Figures

Figure 1: Evolution & Transition of Immunosuppressant Drugs
Figure 2: Porter's Five Force Analysis
Figure 3: Asia-Pacific Immunosuppressant Drugs Market, by Corticosteroids, 2019-2028 (In $ Million)
Figure 4: Asia-Pacific Immunosuppressant Drugs Market, by Monoclonal Antibodies, 2019-2028 (In $ Million)
Figure 5: Asia-Pacific Immunosuppressant Drugs Market, by Calcineurin Inhibitors, 2019-2028 (In $ Million)
Figure 6: Asia-Pacific Immunosuppressant Drugs Market, by Mtor Inhibitors, 2019-2028 (In $ Million)
Figure 7: Asia-Pacific Immunosuppressant Drugs Market, by Others, 2019-2028 (In $ Million)
Figure 8: Asia-Pacific Immunosuppressant Drugs Market, by Hospital Pharmacies, 2019-2028 (In $ Million)
Figure 9: Asia-Pacific Immunosuppressant Drugs Market, by Retail Pharmacies, 2019-2028 (In $ Million)
Figure 10: Asia-Pacific Immunosuppressant Drugs Market, by Online Pharmacies, 2019-2028 (In $ Million)
Figure 11: Asia-Pacific Immunosuppressant Drugs Market, by Organ Transplantation, 2019-2028 (In $ Million)
Figure 12: Asia-Pacific Immunosuppressant Drugs Market, by Autoimmune Disorders, 2019-2028 (In $ Million)
Figure 13: Asia-Pacific Immunosuppressant Drugs Market, by Others, 2019-2028 (In $ Million)
Figure 14: Asia-Pacific Immunosuppressant Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 15: China Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 16: Japan Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 17: India Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 18: South Korea Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 19: Asean Countries Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 20: Australia & New Zealand Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 21: Rest of Asia-Pacific Immunosuppressant Drugs Market, 2019-2028 (In $ Million)